Literature DB >> 21893939

Amygdala regulation of fear and emotionality in fragile X syndrome.

Jose Luis Olmos-Serrano1, Joshua G Corbin.   

Abstract

Fear is a universal response to a threat to one's body or social status. Disruption in the detection and response of the brain's fear system is commonly observed in a variety of neurodevelopmental disorders, including fragile X syndrome (FXS), a brain disorder characterized by variable cognitive impairment and behavioral disturbances such as social avoidance and anxiety. The amygdala is highly involved in mediating fear processing, and increasing evidence supports the idea that inhibitory circuits play a key role in regulating the flow of information associated with fear conditioning in the amygdala. Here, we review the known and potential importance of amygdala fear circuits in FXS, and how developmental studies are critical to understand the formation and function of neuronal circuits that modulate amygdala-based behaviors.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21893939      PMCID: PMC3254036          DOI: 10.1159/000329424

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  142 in total

Review 1.  Cortical pathways to the mammalian amygdala.

Authors:  A J McDonald
Journal:  Prog Neurobiol       Date:  1998-06       Impact factor: 11.685

2.  The catecholaminergic innervation of the rat amygdala.

Authors:  E Asan
Journal:  Adv Anat Embryol Cell Biol       Date:  1998       Impact factor: 1.231

3.  Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation.

Authors:  I J Weiler; S A Irwin; A Y Klintsova; C M Spencer; A D Brazelton; K Miyashiro; T A Comery; B Patel; J Eberwine; W T Greenough
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

4.  Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain.

Authors:  M Abitbol; C Menini; A L Delezoide; T Rhyner; M Vekemans; J Mallet
Journal:  Nat Genet       Date:  1993-06       Impact factor: 38.330

Review 5.  GABAergic and endocannabinoid dysfunction in anxiety - future therapeutic targets?

Authors:  K Domschke; P Zwanzger
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

6.  Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles.

Authors:  Edouard W Khandjian; Marc-Etienne Huot; Sandra Tremblay; Laetitia Davidovic; Rachid Mazroui; Barbara Bardoni
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-25       Impact factor: 11.205

7.  FMR1 protein: conserved RNP family domains and selective RNA binding.

Authors:  C T Ashley; K D Wilkinson; D Reines; S T Warren
Journal:  Science       Date:  1993-10-22       Impact factor: 47.728

8.  Evidence for social anxiety and impaired social cognition in a mouse model of fragile X syndrome.

Authors:  Caitlyn H McNaughton; Jisook Moon; Myla S Strawderman; Kenneth N Maclean; Jeffrey Evans; Barbara J Strupp
Journal:  Behav Neurosci       Date:  2008-04       Impact factor: 1.912

Review 9.  Lessons from fragile X regarding neurobiology, autism, and neurodegeneration.

Authors:  Randi J Hagerman
Journal:  J Dev Behav Pediatr       Date:  2006-02       Impact factor: 2.225

10.  Identification of a signaling network in lateral nucleus of amygdala important for inhibiting memory specifically related to learned fear.

Authors:  Gleb P Shumyatsky; Evgeny Tsvetkov; Gaël Malleret; Svetlana Vronskaya; Michael Hatton; Lori Hampton; James F Battey; Catherine Dulac; Eric R Kandel; Vadim Y Bolshakov
Journal:  Cell       Date:  2002-12-13       Impact factor: 41.582

View more
  5 in total

Review 1.  Mechanisms Driving the Emergence of Neuronal Hyperexcitability in Fragile X Syndrome.

Authors:  Pernille Bülow; Menahem Segal; Gary J Bassell
Journal:  Int J Mol Sci       Date:  2022-06-05       Impact factor: 6.208

2.  Homeostatic responses fail to correct defective amygdala inhibitory circuit maturation in fragile X syndrome.

Authors:  Rebecca L Vislay; Brandon S Martin; Jose Luis Olmos-Serrano; Sebila Kratovac; David L Nelson; Joshua G Corbin; Molly M Huntsman
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

3.  Elevated FMR1-mRNA and lowered FMRP - A double-hit mechanism for psychiatric features in men with FMR1 premutations.

Authors:  Andrea Schneider; Tri Indah Winarni; Ana María Cabal-Herrera; Susan Bacalman; Louise Gane; Paul Hagerman; Flora Tassone; Randi Hagerman
Journal:  Transl Psychiatry       Date:  2020-06-23       Impact factor: 6.222

Review 4.  Fragile X Syndrome: From Molecular Aspect to Clinical Treatment.

Authors:  Dragana D Protic; Ramkumar Aishworiya; Maria Jimena Salcedo-Arellano; Si Jie Tang; Jelena Milisavljevic; Filip Mitrovic; Randi J Hagerman; Dejan B Budimirovic
Journal:  Int J Mol Sci       Date:  2022-02-09       Impact factor: 5.923

Review 5.  The contribution of inhibitory interneurons to circuit dysfunction in Fragile X Syndrome.

Authors:  Christian A Cea-Del Rio; Molly M Huntsman
Journal:  Front Cell Neurosci       Date:  2014-08-25       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.